Canopy Growth to Report Second Quarter Fiscal 2026 Financial Results on November 7, 2025 SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation ("Canopy Growth†or the "Company†) (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2026 ended September 30, 2025 before financial markets open on November 7, 2025. Following the release of its second quarter fiscal year 2026 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and ...

Top 3 Canadian Cannabis Stocks to Watch in October 2025The Canadian cannabis sector continues to attract attention as investors look for opportunities amid renewed optimism surrounding U.S. legalization. The U.S. cannabis industry is projected to exceed $40 billion in annual sales by 2026, reflecting steady growth despite regulatory delays. Recent headlines about federal rescheduling discussions and state-level legalization measures have reignited momentum across both Canadian and American operators. As a r ...

 A New Phase for Legal CannabisThe legal cannabis industry is entering a new stage of expansion in 2025. Across North America, lawmakers, investors, and entrepreneurs are driving major change. Although the U.S. still lacks federal legalization, state reforms and public support continue to build momentum. As more states open their markets, new business opportunities are emerging in cultivation, retail, and product innovation.Global Market ExpansionBillions in Growth AheadThe global cannabis market keeps grow ...

Top Canadian Weed Stocks to Watch Now as U.S. Reform ApproachesThe Canadian cannabis sector continues to attract investors as North American legalization momentum gains strength. Recently, U.S. regulators advanced discussions on cannabis rescheduling, signaling a potential shift toward federal reform. This news lifted optimism across the industry, especially for Canadian producers eyeing future U.S. market entry. Currently, the U.S. cannabis market generates over $35 billion in annual sales and is projected ...

Core Insights - Canopy Growth Corporation has transitioned its DOJA facility in Kelowna, British Columbia to operate exclusively as a medical cultivation site [1] - The Kelowna facility will focus on cultivating small-batch, BC-grown craft cannabis to support the Company's Spectrum Therapeutics portfolio in Canada [1] Company Developments - The decision to operate the DOJA facility solely for medical purposes aligns with Canopy Growth's commitment to enhancing the therapeutic potential of cannabis [1] - The shift to small-batch cultivation emphasizes quality and local sourcing, which may enhance the brand's reputation in the medical cannabis market [1]

Core Insights - JP Brand Advisors and Canopy USA have formed a strategic partnership to enhance the distribution of Wana Wellness's hemp-based beverages and gummies in the U.S. market [1][3] - The partnership highlights the growing focus on hemp-based functional beverages, which are gaining traction due to increasing consumer demand for wellness-oriented products [2][4] Company Overview - JP Brand Advisors acts as an outsourced sales and strategy partner for beverage alcohol and emerging functional beverage brands, providing market coverage and distributor management [5] - Canopy USA is a holding company with a significant interest in the U.S. cannabis market, owning Wana Brands, a leader in North American edibles, and other cannabis-related entities [6] Market Trends - There is a rising interest among U.S. retailers and distributors in non-alcoholic, functional, and hemp-infused beverages, driven by changing consumer preferences and clearer regulations in key markets [4]

Core Insights - Cannabis stocks experienced significant movement following President Trump's endorsement of cannabidiol (CBD) for seniors, highlighting potential health benefits [1] - Major marijuana stocks saw substantial gains, with Tilray Brands increasing by 42% and Aurora Cannabis by 25%, although some of these gains were later reversed [2] Company Overview - Constellation Brands is a significant shareholder in Canopy Growth, holding approximately 26 million shares through its shell company, which could represent about 14% of Canopy's stock if converted [3] - Constellation Brands is the third-largest beer company in the U.S., also producing high-end wine and spirits, with notable brands like Corona and Kim Crawford [4] Financial Performance - Constellation Brands has a market capitalization of $24.5 billion and has seen a year-to-date decline of 37% in 2025, underperforming competitors like Boston Beer and Molson Coors [5] - The stock is currently considered overvalued with a price-to-earnings ratio of 46.4, significantly higher than its 10-year median of 25.8 [5] Dividend Information - Constellation Brands offers a dividend yield of 3%, which is above the sector average of 1.9%, with the next payment scheduled for November 13, 2025 [6]

Company Performance - Canopy Growth Corporation (CGC) closed at $1.36, reflecting a -1.45% change from the previous day's closing price, underperforming the S&P 500 which gained 0.06% [1] - Over the past month, shares of Canopy Growth have decreased by 1.43%, while the Medical sector and S&P 500 gained 5.06% and 3.94% respectively [1] Earnings Expectations - The upcoming earnings report is expected to show an EPS of -$0.11, which is an improvement of 88.42% from the same quarter last year [2] - Revenue is anticipated to be $52.34 million, indicating a 13.34% increase from the prior year quarter [2] - For the full year, earnings are projected at -$0.5 per share and revenue at $219.38 million, representing increases of 83.22% and 13.49% respectively from the previous year [3] Analyst Estimates and Rankings - Recent modifications to analyst estimates for Canopy Growth are crucial as they reflect changing business trends and analysts' confidence in performance [4] - The Zacks Rank system, which evaluates these estimate changes, currently ranks Canopy Growth as 2 (Buy), indicating positive sentiment [6] - The Zacks Industry Rank places the Medical - Products industry in the top 35% of over 250 industries, suggesting strong performance potential [7]

Group 1 - The cannabis sector has been gaining momentum since August due to a positive policy shift towards cannabis, supported by President Trump's comments on rescheduling and promoting medical cannabis [1] - The article emphasizes the importance of thorough research and analysis of financial statements, market trends, and upcoming events that may impact specific companies or industries [1]

Industry Overview - The cannabis sector is currently facing significant challenges, characterized by volatility, heavy regulation, and a lack of long-term profitability among many companies [2] - Despite these challenges, potential policy changes and renewed investor interest keep the industry relevant, with valuations significantly down, allowing for potential stock price movements with small catalysts [2][12] Company Summaries Tilray Brands - Tilray has evolved into a consumer packaged goods conglomerate, owning eight craft beer brands and generating $240.6 million in beverage sales, a 19% increase year over year, compared to $249 million from cannabis [4] - Total revenue for fiscal 2025 reached $821.3 million, up 4% year over year, with international cannabis revenue increasing by 71% [5] - The company ended the fiscal year with $256.4 million in cash and marketable securities, providing financial flexibility, although it continues to post GAAP losses due to impairments and restructuring charges [5] Canopy Growth - Canopy Growth is viewed as a bellwether for the cannabis industry, often leading market movements due to its brand recognition and significant investment from Constellation Brands [6] - In fiscal 2026 Q1, Canopy reported consolidated net revenue of CA$72.1 million, a 9% increase year over year, with cannabis revenue at CA$57 million [7] - The company reported an adjusted EBITDA loss of CA$7.9 million and a free cash flow outflow of CA$12 million, although this represented a 79% improvement from the previous year [7][8] Innovative Industrial Properties - Innovative Industrial Properties operates as a real estate investment trust (REIT), focusing on collecting rents from cannabis operators, owning 108 properties across 19 states [9] - In the second quarter, the company reported $62.9 million in revenue, a 21% decline from the prior year due to tenant defaults, yet maintained a quarterly dividend of $1.90 per share, yielding nearly 14% [10] - The risk for Innovative Industrial Properties lies in potential rent defaults if cannabis operators continue to struggle, which could lead to vacant properties or the need for lease renegotiations [11] Investment Opportunities - The three highlighted companies provide distinct investment approaches within the cannabis sector: Tilray offers diversification through beverages, Canopy provides leverage to market sentiment, and Innovative Industrial Properties delivers income while waiting for market improvements [12] - The cannabis industry is down 80% from its 2021 highs, and October often brings speculation about policy shifts, suggesting that even modest catalysts could lead to significant share price movements [13]